Unibest
← Back to patent-cliff list

Canagliflozin Hemihydrate

Tier C — Watch / trade

Canagliflozin Hemihydrate

Mitsubishi Tanabe Pharma Corporation
Originator
2013
First approval
-
Expiry (public)
$0.1B ▲
Peak sales
Small molecule
Type

Targets:SGLT2

Brand:Invokana, Canaglu

Indications (approved):Type 2 diabetes, Diabetic nephropathy

Regional status

US
Approved
2013-03-29
EU
Approved
2013-11-15
China
Approved
2017-09-29
Japan
Approved
2014-07-04

Factories producing this API1

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

1 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates3 routes

Originator routes × 2Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 33.5 g
CANA-00179669-49-1CANA-00221900-41-4CANA-00358861-48-6CANA-0041132832-75-7CANA-0051030825-20-7CANA-00632384-65-9CANA-0071672658-93-3CANA-0081030825-21-8API · Canagliflozin Hemihydrate
CodeCAS No.Intermediate
CANA-00179669-49-15-bromo-2-methylbenzoic acid
CANA-00221900-41-45-bromo-2-methylbenzoyl chloride
CANA-00358861-48-6Available2-(4-fluorophenyl)thiophene
CANA-0041132832-75-7(5-bromo-2-methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)methanone
CANA-0051030825-20-7Available2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
CANA-00632384-65-9Available(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one
CANA-0071672658-93-3(3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol
CANA-0081030825-21-8(3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
OriginatorRoute 2Steps 5 · Total yield /
CANA-00358861-48-6CANA-0091003-09-4CANA-010460-00-4CANA-011108440-70-6CANA-012898566-17-1CANA-01361259-48-1CANA-0141071929-02-6CANA-015866607-35-4API · Canagliflozin Hemihydrate
CodeCAS No.Intermediate
CANA-00358861-48-6Available2-(4-fluorophenyl)thiophene
CANA-0091003-09-42-bromothiophene
CANA-010460-00-41-bromo-4-fluorobenzene
CANA-011108440-70-65-iodo-2-methylbenzoyl chloride
CANA-012898566-17-1Available2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene
CANA-01361259-48-1(2R,3R,4S,5R)-2-(acetoxymethyl)-6-oxotetrahydro-2H-pyran-3,4,5-triyl triacetate
CANA-0141071929-02-6(3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate
CANA-015866607-35-4Available(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
OptimisedRoute 3Steps 4 · Total yield /
CANA-012898566-17-1CANA-016492-62-6CANA-0171213234-53-7CANA-01881058-27-7CANA-0191283129-18-9API · Canagliflozin Hemihydrate
CodeCAS No.Intermediate
CANA-012898566-17-1Available2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene
CANA-016492-62-6(2S,3R,4S,5S,6R)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol
CANA-0171213234-53-7(2R,3R,4S,5R,6R)-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(2,2-dimethylpropanoate)
CANA-01881058-27-7(2R,3R,4S,5R,6R)-2-bromo-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-3,4,5-triyl tris(2,2-dimethylpropanoate)
CANA-0191283129-18-9(2S,3S,4R,5R,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-3,4,5-triyl tris(2,2-dimethylpropanoate)

Frequently asked questions

What are the approved indications of Canagliflozin Hemihydrate?

Approved indications include: Type 2 diabetes, Diabetic nephropathy.

When does the Canagliflozin Hemihydrate patent expire?

No public expiry year is available for Canagliflozin Hemihydrate yet; this page updates once verified.

How many synthesis routes are recorded for Canagliflozin Hemihydrate?

3 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Canagliflozin Hemihydrate intermediates?

5 intermediate CAS of Canagliflozin Hemihydrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Canagliflozin Hemihydrate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29